Respiratory diseases drugs market covers drugs that are used in the treatment of a wide range of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), chronic and acute bronchitis, emphysema and cystic fibrosis. Some of the major drugs in the market include antimuscarinics, corticosteroids, Codral®, Coldrex® and Lemsip®.
North America was the largest region in the respiratory diseases drugs market in 2017, accounting for 48% market share. This was mainly due to high number of patients with respiratory diseases, more people covered under medical insurance programs and higher pricing of medications in the USA. Asia Pacific was the second largest region accounting for 19% market share. Africa was the smallest region accounting for 2% market share. This is attributed to the small size of population in the region.
The demand for PSE-containing cold, allergy, and sinus products is growing due to their effectiveness and convenience. PSE is an active ingredient found in various cold, allergy, and sinus drugs that can provide congestion relief. However, PSE-containing medicines are mostly sold as a prescription drug, as PSE can also be used for the illegal manufacture of methamphetamine, a recreational drug. This has led drug manufacturers to produce tamper-resistant PSE products. For instance, in March 2017, pharmaceutical companies Acura Pharmaceuticals Inc. and MainPointe Pharmaceuticals LLC entered into an agreement, enabling MainPointe Pharmaceuticals LLC to market NEXAFED and NEXAFED Sinus products in the US and Canada. These drugs utilize tamper-resistant PSE formulation to prevent the illicit production of methamphetamine.
Companies Covered: GlaxosmithKline Plc, AstraZeneca Plc, Merck & Co, Novartis AG, Johnson & Johnson
Market segments Included: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations
Opioids and Other Analgesics Are The Fastest-Growing Neurology Drugs
North America`s Cardiovascular Drugs Market To Shrink 5% 2013-21
Biologics Logistics Outsourcing Market Growth Nearly Twice Other Pharma`s
Challenges To Big Pharma Are Helping Drive The Bio-Pharmaceutical Logistics Market
Over 1000 Biologics Under Development Will Drive The Biologics Market To 10% Yearly Growth
Public Policy Restrains Blood Glucose Test Strips Market Growth
The Leading Players In The Cardiovascular Devices Market Are Innovating To Stay Ahead
India Is The World’s Fastest-Growing Market For In-Vitro Diagnostics
Veterinary Services Global Market Report 2018
Blood Glucose Test Strips Global Market Report 2018
Nephrology And Urology Devices Market Global Briefing 2018
Neurology Devices Market Global Briefing 2018
ENT Devices Market Global Briefing 2018
Orthopedic Devices Market Global Briefing 2018
Wound Care Devices Market Global Briefing 2018
Diabetes Care Devices Market Global Briefing 2018